Search Results 241-250 of 24110 for prostate cancer
D., is a urologist with an interest in prostate cancer, benign prostatic hyperplasia, and prostate health. He is a urologic surgeon with a clinical practice ...
This tool, which was studied using prostate cancer animal and cell models, consists of human-made protein complexes, called "proteolysis-targeting chimeras," ...
Henderson credits the yearly annual exam and comprehensive care he receives at Mayo Clinic with an early detection of prostate cancer about five years ago.
AZD5305 Vs Placebo In Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents · Overview · Participation ...
The study is the first to capture the methylation changes that occur across the entire human genome in prostate cancer. It's published in the journal Clinical ...
Evaluating men for prostate cancer recurrence has long been a major challenge; physicians have had to wait until a patient's prostate-specific antigen (PSA) ...
Androgens can cause the growth of prostate cancer cells. Androgen-deprivation therapy may lessen the amount of androgens made by the body. It is not yet known ...
... prostate cancer. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...
Each year about 90,000 men seek treatment for recurrent prostate cancer, and evaluating them for recurrence is a major challenge.
The methods used to anesthetize prostate cancer patients and control pain when their prostate glands are surgically removed for adenocarcinoma may affect their ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift today can have 5X the impact on AI research and technology. But hurry — the match challenge ends 9/19.